Weed legalisation linked to drop in alcohol, tobacco consumption, study says

Business
May.19.2022
Weed legalisation linked to drop in alcohol, tobacco consumption, study says

Cannabis legalisation is linked to a reduction in alcohol and cigarette consumption, as well as pain medication misuse among young adults, a new study has suggested.

 

The research, published last week in the Journal of Adolescent Health, assessed trends in alcohol, nicotine, and non-prescribed pain reliever use in Washington State following the legalisation of cannabis for recreational use in 2012.

 

Scientists, including those from the University of Washington, analysed data from six annual waves of surveys from 2014 through 2019, covering 12,500 young adults of ages 18 to 25.

 

While previous studies have debunked the idea that cannabis is a so-called “gateway drug”, leading to the consumption of other, potentially more dangerous controlled substances, the new research 

confirms that cannabis legalisation does not lead to drastic increases in the use of alcohol and cigarettes or the misuse of non-prescribed opioids.

 

It found that the prevalence of past-month alcohol use, heavy episodic drinking (HED), and cigarette use and prevalence of past-year pain reliever misuse decreased among the cohort.

 

“Across years and age groups, the prevalence of substance use other than cannabis was higher among occasional and frequent cannabis users compared to cannabis non-users,” scientists wrote.

 

“Contrary to concerns about spillover effects, implementation of legalized nonmedical cannabis coincided with decreases in alcohol and cigarette use and pain reliever misuse,” they added.

 

However, the study found that the prevalence of e-cigarette use among the cohort rose during the timeframe of the assessment, likely due to the overall growth in consumption of vapes during this period in the US and not necessarily linked to cannabis legalisation.

 

Previous research has also shown that legalising weed can help people depend less on alcohol and other controlled substances.

 

A study published earlier this year found that cannabis legalisation is linked to reduced use of prescription medication for treating anxiety, pain, sleep, as well as seizures.

 

Another study in 2019 also found that recreational and medical cannabis access laws reduce morphine use.

 

While the link between cannabis use and the consumption of other controlled substances needs further research, scientists say the new findings point to the increased significance of cannabis-specific prevention and treatment efforts.

 

Source:yahoo

Vape Vending Machine Concerns Rise in German-Speaking Europe as Schools and Age Checks Come Into Focus
Vape Vending Machine Concerns Rise in German-Speaking Europe as Schools and Age Checks Come Into Focus
Recent reports from Germany and Switzerland show growing concern over vape and tobacco vending machines near schools or in public settings, with parents, teachers and residents questioning youth access, age-verification controls and the sale of vapes alongside snacks and drinks.
Jul.06
Germany Plans Tobacco Tax Hike, With Cigarette Prices Nearing €12 Per Pack by 2030
Germany Plans Tobacco Tax Hike, With Cigarette Prices Nearing €12 Per Pack by 2030
Germany plans to raise tobacco taxes over the coming years, potentially pushing the average price of a 20-cigarette pack to about €11.78 by 2030. The proposal also covers fine-cut tobacco, cigars, pipe tobacco and e-cigarette liquids.
Jul.14
Yinghe-Controlled Vape Maker SKE Ordered to Post £569,039 Security as It Pursues Crystal Bar Design Infringement Case in UK
Yinghe-Controlled Vape Maker SKE Ordered to Post £569,039 Security as It Pursues Crystal Bar Design Infringement Case in UK
The UK High Court has ordered Chinese vape manufacturer Shenzhen SKE Technology to provide £569,039 ($776,000) in security for costs in its design infringement proceedings against Vapepen London and other defendants over its Crystal Bar vape product. The court did not accept the defendants’ main argument that recovering costs from a China-based company would face significant enforcement obstacles, but found that SKE had not sufficiently disclosed its own financial position. The order is procedural and does not determine the underlying infringement claims.
News
Aug.21
Supreme Vape Revenue Rises 15% Despite UK Disposable Vape Ban
Supreme Vape Revenue Rises 15% Despite UK Disposable Vape Ban
UK consumer goods group Supreme said its vaping revenue rose 15% to £148.1 million in the year to March 31, 2026, despite the UK disposable vape ban taking effect during the period, while the company identified the Vaping Products Duty due in October as the next major industry milestone.
Regulations
Jul.03 by 2Firsts Perspectives
Philippine Customs Seizes $2.22 Million in Misdeclared Vape Products From China
Philippine Customs Seizes $2.22 Million in Misdeclared Vape Products From China
The Philippine Bureau of Customs said it intercepted nine containers of misdeclared vape and vape-related products from China at the Manila International Container Port, with an estimated value of about ₱137 millionor, about $2.22 million.
Jul.10
Australia’s Daily Smoking Rate Falls to Record Low of 5.8% as Nicotine Use Patterns Shift
Australia’s Daily Smoking Rate Falls to Record Low of 5.8% as Nicotine Use Patterns Shift
According to the Australian Institute of Health and Welfare’s National Drug Strategy Household Survey, daily smoking among Australians aged 18 and over fell to a record low of 5.8% in 2025. Health Minister Mark Butler said Australia now has around 500,000 fewer daily smokers than three years ago and credited the government’s vaping reforms as part of broader progress. Among people aged 14 and over, daily smoking declined from 8.3% in 2022-23 to 5.6% in 2025. Daily vaping rates stabilised at 3.6%, while the government also moved to further restrict access to nicotine pouches through unapproved therapeutic import pathways.
Jul.21